NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIMH E-281-2005-0-US-01 Quantum-dot/bacteriophage (PhageQdot) To Detect Biological Target In Clinical Or Enviromental Isolates US 60/654,784 Abandoned
NHGRI E-068-2005-0-US-01 Identification Of Molecular Diagnostic Markers For Endometriosis In Blood Lymphocytes US 60/654,331 Abandoned
NIAID E-123-2005-0-US-01 The HIV Gp-41-Membrane Proximal Region Arrayed on Hepatitis B Surface Antigen Particles as Novel Antigens US 60/653,930 Abandoned
NIAID E-233-2003-2-US-01 Inhibition Of HIV-1 Replication By Disruption Of The Processing Of The Viral Capsid-Spacer Peptide 1 Protein US 60/653,961 Abandoned
NCI E-019-2005-0-US-01 Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors US 60/654,329 Abandoned
NCI E-191-2002-0-GB-13 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF GB EP 03751813.1 Expired
NCI E-191-2002-0-DE-11 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF DE EP 03751813.1 Expired
NCI E-191-2002-0-FR-12 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF FR EP 03751813.1 Expired
NCI E-142-1990-2-US-05 AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY US CON 11/060,102 7939635 Abandoned PDF
NCI E-342-2003-0-US-03 Hepatitis C Viral-Like Particle Purification US National Stage 10/524,443 Abandoned
NIAID E-093-2000-0-US-03 Methods of Diagnosing Multidrug Resistant Tuberculosis US DIV 11/058,484 7547519 Expired PDF
NCI E-277-2005-0-US-01 Development Of An Ultra-sensitive And Specific Biosensor For Anthrax Therapeutics And Diagnostics US 60/653,230 Abandoned
NCI E-207-2004-1-US-01 Generation Of Plasmids With The Prophage Lamba Immunity Region, PL Promoter, And Red Genes For Transfer To Other Gram Negative Bacteria For The Purpose Of Recombineering In Those Organisms US 60/653,259 Abandoned
NCI E-073-2004-0-PCT-02 Reduction of HIV-1 Replication by a Mutant Of Human Apolipoprotein B MRNA Editing Enzyme-Catalytic Polypeptide-like 3G (APOBEC3G) PCT PCT PCT/US2005/004371 Expired
NCI E-013-2001-0-US-04 REITERATIVELY LAYERED MEDICAL DEVICES AND METHOD OF PREPARING SAME. US CON 11/056,323 Abandoned
NCI E-018-2005-0-US-01 Method of Diagnosing Cancer Using Beta-Catenin Splice Variants US 60/652,154 Abandoned
NIAID E-282-1998-0-AU-08 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases AU DIV 2005200592 Abandoned
NIAID E-059-2004-0-US-02 Multimeric Protein Toxins to Target Cells Having Multiple Identifying Characteristics US ORD 11/055,557 7947289 Issued PDF
NIAID E-043-2000-0-US-05 Major Neutralization Site Of Hepatitis E Virus And Use Of This Neutralization Site In Methods Of Vaccination And In Methods Of..... US CON 11/054,041 7148323 Abandoned PDF
NIAID E-059-2004-0-PCT-03 Multimeric Protein Toxins To Target Cells Having Multiple Identifying Characteristics PCT PCT PCT/US2005/04216 Expired
NICHD E-111-2005-0-US-01 Metabolomics In Premature Labor: A Novel Approach To Identify Patients At Risk For Preterm Delivery US 60/650,977 Abandoned
NIAID E-225-2000-0-US-14 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes US CON 11/054,343 7662397 Expired PDF
NCI E-001-1989-1-US-04 HUMAN DERIVED MONOCYTE ATTRACTING PURIFIED PROTEIN PRODUCT USEFUL IN A METHOD OF TREATING INFECTION AND NEOPLASM IN A HUMAN BODY, AND THE CLONING OF FULL LENGTH cDNA THEREOF US DIV 11/055,587 7319091 Expired PDF
CC E-061-2003-0-PCT-02 Long Term Retrieveable Venous Filter PCT PCT PCT/US2005/04076 Expired
NHLBI E-062-2006-0-US-03 Thymic Stromal Lymphopoietin Receptor Molecules And Uses Thereof US DIV 11/052,527 7402659 Expired PDF
NHLBI E-062-2006-0-US-04 Thymic Stromal Lymphopoietin Receptor Molecules And Uses Thereof US DIV 11/052,427 Abandoned
NCI E-010-2004-2-PCT-01 Activation Of T Cell P38 By Src Kinase-Mediated Tyrosine Phosphorlation: Negative Regulation By The Autoimmune Suppressor Gadd45a PCT PCT COMB PCT/US2005/03379 Abandoned
NHLBI E-061-2004-1-PCT-01 A Novel System For The Complete Removal Of All Mucus From Within The Trachael Tube: The Mucus Shaver With Bacteriocidal Properties PCT PCT COMB PCT/US2005/003395 Expired
NICHD E-181-2004-0-US-01 Preparation And Use Of Androgenic Compounds US 60/650,376 Abandoned
NIAID E-270-2004-0-US-01 Oxygenation Inhibits The Phsiological Tissue-protecting Mechanism And Thereby Exacerbates Acute Inflammatory Lung Injury US 60/650,267 Abandoned
NCI E-101-2005-0-US-01 Compounds Useful in the Treatment of Cancer and Methods for Selecting Such Compounds US 60/650,026 Abandoned
NIAID E-178-1999-3-US-01 Production Of Attenuated, Human-bovine Chimeric Respiratory Syncytial Virus Vaccines US CIP 11/051,589 Abandoned
NIAID E-178-2008-2-US-01 Molecular Scaffolds for HIV-1 Epitopes US 60/649,551 Abandoned
NINDS E-261-2004-0-PCT-02 Peptidic Compound Mixtures As Therapeutic Agents In CNS Autoimmunity PCT PCT PCT/US2005/002962 Expired
NINDS E-261-2004-0-EP-07 PEPTIDE MIXTURES WITH IMMUNOMODULATORY ACTIVITY EP National Stage 05712417.4 Abandoned
NINDS E-261-2004-0-AU-05 Peptidic Compound Mixtures As Therapeutic Agents In CNS Autoimmunity AU National Stage 2005211424 Abandoned
NINDS E-261-2004-0-CA-06 Peptidic Compound Mixtures As Therapeutic Agents In CNS Autoimmunity CA National Stage 2556152 Abandoned
NCI E-082-2005-0-US-01 Sipa-1 Gene and Sipa-1 IInhibitor For the Treatment, Prevention, and Diagnosis of Cancer US 60/649,365 Abandoned
NCI E-064-2005-0-US-01 BIOMARKERS FOR TISSUE STATUS US 60/649,208 Abandoned
NCI E-104-2005-0-US-01 Alpha-defensins As Topical Inhibitors Of Human Papillovirus Infection US 60/649,248 Abandoned
NCI E-103-2005-0-US-01 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies US 60/649,249 Abandoned
NICHD E-280-2002-0-US-03 Measurement Systems and Methods US National Stage 11/046,199 Abandoned
NCI E-306-2000-0-US-05 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITION COMPRISING SAME AND METHODS OF MAKING SAME. US National Stage 10/523,123 Abandoned
NHGRI E-055-2005-0-US-01 Methods And Use Of Farnesyl Transferase Inhibitors (FTIs) For Laminopathies, Cellular Aging, And Artherosclerosis US 60/648,307 Abandoned
NINDS E-143-2002-1-AT-16 Method For the Treatment of Multiple Sclerosis AT EP 03762181.0 Abandoned
NINDS E-143-2002-1-BG-18 Method For the Treatment of Multiple Sclerosis BG EP 03762181.0 Abandoned
NINDS E-143-2002-1-BE-17 Method For the Treatment of Multiple Sclerosis BE EP 03762181.0 Abandoned
NINDS E-143-2002-1-FI-36 Method For the Treatment of Multiple Sclerosis FI EP 03762181.0 Abandoned
NINDS E-143-2002-1-DE-34 Method For the Treatment of Multiple Sclerosis DE EP 03762181.0 Abandoned
NINDS E-143-2002-1-LI-38 Method For the Treatment of Multiple Sclerosis LI EP 03762181.0 Abandoned